Back to Search
Start Over
Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies.
- Source :
-
Leukemia [Leukemia] 2022 Mar; Vol. 36 (3), pp. 877-880. Date of Electronic Publication: 2021 Nov 20. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 36
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Editorial & Opinion
- Accession number :
- 34802043
- Full Text :
- https://doi.org/10.1038/s41375-021-01471-3